Literature DB >> 20921264

Can a 12-step program work in methadone maintenance treatment?

Natti Ronel1, Keren Gueta, Yali Abramsohn, Nir Caspi, Miriam Adelson.   

Abstract

Three consecutive, professionally led (as opposed to self-help) groups following the 12-step program (TSP) were integrated into a methadone maintenance treatment (MMT) program that included 32 heroin-addicted individuals in recovery. This report describes our experience in meeting the challenges that arose and our conclusions regarding the therapeutic potential of this integration. A professional therapeutic staff guided the groups. In-depth interviews of 10 participants and the reflections of the group leaders provided data for learning about the groups' experience. Initially the participants rejected the concepts of Step 1, powerlessness and unmanageability of life. The assimilation of Step 4 (defining character defect) also aroused some resistance. The participants eventually adopted the pragmatic aspects of TSP, including its terminology. The establishment of a common language of recovery helped to create group coherence and a sense of belonging, and helped to meet the needs of those who felt stigmatized by both the nonaddicted and addicted population undergoing nonmethadone recovery. TSP could be adapted to various aspects of daily life, produced a sense of self-efficacy, and stimulated motivation for change. Therapeutic implications are discussed.
© 2011 SAGE Publications

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921264     DOI: 10.1177/0306624X10382570

Source DB:  PubMed          Journal:  Int J Offender Ther Comp Criminol        ISSN: 0306-624X


  8 in total

1.  Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence.

Authors:  Roger D Weiss; Margaret L Griffin; David E Marcovitz; Blake T Hilton; Garrett M Fitzmaurice; R Kathryn McHugh; Kathleen M Carroll
Journal:  J Clin Psychiatry       Date:  2019-03-26       Impact factor: 4.384

2.  Buprenorphine Treatment and 12-step Meeting Attendance: Conflicts, Compatibilities, and Patient Outcomes.

Authors:  Laura B Monico; Jan Gryczynski; Shannon Gwin Mitchell; Robert P Schwartz; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2015-05-12

3.  The impact of self-help groups on successful substance use treatment completion for opioid use: An intersectional analysis of race/ethnicity and sex.

Authors:  Madeline R Stenersen; Kathryn Thomas; Cara Struble; Kelly E Moore; Catherine Burke; Sherry McKee
Journal:  J Subst Abuse Treat       Date:  2021-11-20

4.  Impact of research network participation on the adoption of buprenorphine for substance abuse treatment.

Authors:  Traci R Rieckmann; Amanda J Abraham; Anne E Kovas; Bentson H McFarland; Paul M Roman
Journal:  Addict Behav       Date:  2014-02-07       Impact factor: 3.913

5.  Improving psychosocial health and employment outcomes for individuals receiving methadone treatment: a realist synthesis of what makes interventions work.

Authors:  Lois A Jackson; Jane A Buxton; Julie Dingwell; Margaret Dykeman; Jacqueline Gahagan; Karen Gallant; Jeff Karabanow; Susan Kirkland; Dolores LeVangie; Ingrid Sketris; Michael Gossop; Carolyn Davison
Journal:  BMC Psychol       Date:  2014-09-07

6.  "Don't Judge a Book Its Cover": A Qualitative Study of Methadone Patients' Experiences of Stigma.

Authors:  Julia Woo; Anuja Bhalerao; Monica Bawor; Meha Bhatt; Brittany Dennis; Natalia Mouravska; Laura Zielinski; Zainab Samaan
Journal:  Subst Abuse       Date:  2017-03-23

7.  Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?

Authors:  Hagit Bonny-Noach
Journal:  Isr J Health Policy Res       Date:  2019-10-16

8.  Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation.

Authors:  Randi Sokol; Mark Albanese; Aaronson Chew; Jessica Early; Ellie Grossman; David Roll; Greg Sawin; Dominic J Wu; Zev Schuman-Olivier
Journal:  Addict Sci Clin Pract       Date:  2019-12-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.